Psychedelics and Brain Neuroplasticity: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
== Introduction == | == Introduction == | ||
Psychedelics are a type of serotonin (a neurotransmitter) receptor agonist that can lead to intense alerations in perception, cognition and mood<ref>Kwan AC, Olson DE, Preller KH, Roth BL. [https://www.nature.com/articles/s41593-022-01177-4 The neural basis of psychedelic actio]n. Nature Neuroscience. 2022 Nov;25(11):1407-19.Available:https://www.nature.com/articles/s41593-022-01177-4 (accessed 3.10.2023)</ref>. | Psychedelics are a type of serotonin (a neurotransmitter) receptor agonist that can lead to intense alerations in perception, cognition and mood<ref>Kwan AC, Olson DE, Preller KH, Roth BL. [https://www.nature.com/articles/s41593-022-01177-4 The neural basis of psychedelic actio]n. Nature Neuroscience. 2022 Nov;25(11):1407-19.Available:https://www.nature.com/articles/s41593-022-01177-4 (accessed 3.10.2023)</ref>. Psychedelics are recently being identified as a possible option to treat a wide range of brain disorders including depression, post-traumatic stress disorder (PTSD), and substance use disorder and possibly even prove to have therapeutic potential for treatment of neurodegenerative disorders.<ref>Saeger HN, Olson DE. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126991/ Psychedelic‐inspired approaches for treating neurodegenerative disorders]. Journal of Neurochemistry. 2022 Jul;162(1):109-27.Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126991/ (accessed 3.10.2023)</ref> | ||
== Sub Heading 2 == | == Sub Heading 2 == | ||
Revision as of 07:20, 3 October 2023
Original Editor - Lucinda hampton
Top Contributors - Lucinda hampton, Vidya Acharya and Kim Jackson
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (3/10/2023)
Introduction[edit | edit source]
Psychedelics are a type of serotonin (a neurotransmitter) receptor agonist that can lead to intense alerations in perception, cognition and mood[1]. Psychedelics are recently being identified as a possible option to treat a wide range of brain disorders including depression, post-traumatic stress disorder (PTSD), and substance use disorder and possibly even prove to have therapeutic potential for treatment of neurodegenerative disorders.[2]
Sub Heading 2[edit | edit source]
Sub Heading 3[edit | edit source]
Resources[edit | edit source]
- bulleted list
- x
or
- numbered list
- x
References[edit | edit source]
- ↑ Kwan AC, Olson DE, Preller KH, Roth BL. The neural basis of psychedelic action. Nature Neuroscience. 2022 Nov;25(11):1407-19.Available:https://www.nature.com/articles/s41593-022-01177-4 (accessed 3.10.2023)
- ↑ Saeger HN, Olson DE. Psychedelic‐inspired approaches for treating neurodegenerative disorders. Journal of Neurochemistry. 2022 Jul;162(1):109-27.Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126991/ (accessed 3.10.2023)
